Udayar Sharvanan E, Marella Krishnaveni, Naidu Shwetha, Sinha Shwetha
Department of Community Medicine, Kodagu Institute of Medical Sciences Government of Karnataka, India.
Department of Conservative and Endodontics, KVG Dental College and Hospital Sullia, Karnataka, India.
J Family Med Prim Care. 2022 May;11(5):2172-2178. doi: 10.4103/jfmpc.jfmpc_2251_21. Epub 2022 May 14.
COVID-19 ongoing pandemic has resulted in millions of deaths globally, and India has recorded the second highest number of confirmed cases till now. In the absence of effective treatment, it becomes crucial to know about the course of the disease in hospital settings for effective patient care. The present study discusses the clinicoepidemiological, haematological and biochemical determinants among survivors and non-survivors of COVID-19 patients admitted to a tertiary care hospital in a hilly area.
A record-based cross-sectional study was carried out at the government hospital from March 2021 to June 2021, which included all confirmed cases of 18 years and above. Demographic details, delayed admission, co-morbidities and laboratory parameters were collected.
Out of a total of 1267 COVID-19 patients, the mean age of survived and succumbed was 50.77 ± 16.1 and 60.50 ± 14.2 years, respectively ( < 0.001). The mean survival time in males (17.7 days) was lesser compared to that in females (20.3 days). Two hundred and twelve of them practised self-medication. The mean duration of delayed testing (2.95 ± 2.3 vs 3.36 ± 2.2 days), mean values of haemoglobin (11.39 ± 2.1 vs 12.5 ± 1.7), platelet count (193.8 ± 94.6 vs 253.1 ± 105.9), leucocyte count (11.53 ± 5.72 vs 9.11 ± 5.21), neutrophil-lymphocyte ratio (10.0 ± 2.9 vs 7.3 ± 3.5), urea (61.16 ± 51.8 vs 30.2 ± 21.2) and creatinine (2.13 ± 2.9 vs. 1.1 ± 0.3) among the two groups were statistically significant ( < 0.001). Increasing age, contact history, hypertension [OR 3.2 (95% CI, 1.40-7.39)], diabetes [OR 1.9 (95% CI, 0.81-4.40)] and chronic kidney disease [OR 15.4 (95% CI, 5.23-45.71)] were found to be associated with increased risk of mortality ( < 0.005).
Public health interventions like contact tracing, testing and early identification of laboratory parameters and treatment on priority would help in providing effective care so that the mortality can be reduced.
新冠疫情在全球已导致数百万例死亡,截至目前,印度确诊病例数位居全球第二。在缺乏有效治疗方法的情况下,了解医院环境中该疾病的病程对于有效护理患者至关重要。本研究探讨了一家位于山区的三级医院收治的新冠患者中幸存者和非幸存者的临床流行病学、血液学和生化指标。
2021年3月至2021年6月在一家政府医院开展了一项基于记录的横断面研究,纳入所有18岁及以上的确诊病例。收集了人口统计学细节、延迟入院情况、合并症和实验室参数。
在总共1267例新冠患者中,幸存者和死亡者的平均年龄分别为50.77±16.1岁和60.50±14.2岁(<0.001)。男性的平均生存时间(17.7天)低于女性(20.3天)。其中212人进行了自我药疗。两组患者的平均延迟检测时间(2.95±2.3天对3.36±2.2天)、血红蛋白平均值(11.39±2.1对12.5±1.7)、血小板计数(193.8±94.6对253.1±105.9)、白细胞计数(11.53±5.72对9.11±5.21)、中性粒细胞与淋巴细胞比值(10.0±2.9对7.3±3.5)、尿素(61.16±51.8对30.2±21.2)和肌酐(2.13±2.9对1.1±0.3)差异有统计学意义(<0.001)。年龄增加、接触史、高血压[比值比3.2(95%置信区间,1.40 - 7.39)]、糖尿病[比值比1.9(95%置信区间,0.81 - 4.40)]和慢性肾脏病[比值比15.4(95%置信区间,5.23 - 45.71)]被发现与死亡风险增加相关(<0.005)。
像接触者追踪、检测以及优先对实验室参数进行早期识别和治疗等公共卫生干预措施,将有助于提供有效的护理,从而降低死亡率。